06-01 Revium Rx. Announces CFO Changes, Effective May 27, 2026 CI
05-14 Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-20 Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026 CI
04-20 Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026 CI
03-31 Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-31 Revium Rx. Auditor Raises 'Going Concern' Doubt CI
01-17 Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
21/10/25 Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections GL
21/10/25 Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections CI
03/10/25 Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/02/25 Revium Rx. has filed an IPO in the amount of $5 million. CI
04/02/25 Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd. GL
04/02/25 Revium Recovery Inc. completed the acquisition of LipoVac, Ltd. CI
21/12/22 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd AQ
20/12/22 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd. AQ
20/12/22 Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd. CI
07/01/21 Revium Recovery Inc. will Change its Ticker to RVRC from OCBG.D CI
17/12/20 Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS GL
09/12/20 OC Beverages, Inc. has Changed its Name to Revium Recovery Inc CI
09/12/20 Revium Recovery Inc. has Changed its Ticker to OCBG.D from OCBG CI
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!